195 related articles for article (PubMed ID: 38417795)
1. Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity.
Hirayama H; Tachida Y; Fujinawa R; Matsuda Y; Murase T; Nishiuchi Y; Suzuki T
J Biol Chem; 2024 Apr; 300(4):107121. PubMed ID: 38417795
[TBL] [Abstract][Full Text] [Related]
2. Assay for the peptide:N-glycanase/NGLY1 and disease-specific biomarkers for diagnosing NGLY1 deficiency.
Hirayama H; Suzuki T
J Biochem; 2022 Feb; 171(2):169-176. PubMed ID: 34791337
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
4. ELISA-based highly sensitive assay system for the detection of endogenous NGLY1 activity.
Fujihira H; Sato K; Nishiuchi Y; Murase T; Matsuda Y; Yoshida Y; Kamei T; Suzuki T
Biochem Biophys Res Commun; 2024 May; 710():149826. PubMed ID: 38581946
[TBL] [Abstract][Full Text] [Related]
5. The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.
Suzuki T; Huang C; Fujihira H
Gene; 2016 Feb; 577(1):1-7. PubMed ID: 26611529
[TBL] [Abstract][Full Text] [Related]
6. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
7. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.
Asahina M; Fujinawa R; Nakamura S; Yokoyama K; Tozawa R; Suzuki T
Hum Mol Genet; 2020 Jun; 29(10):1635-1647. PubMed ID: 32259258
[TBL] [Abstract][Full Text] [Related]
8. A method for assaying peptide: N-glycanase/N-glycanase 1 activities in crude extracts using an N-glycosylated cyclopeptide.
Hirayama H; Tachida Y; Seino J; Suzuki T
Glycobiology; 2022 Mar; 32(2):110-122. PubMed ID: 34939090
[TBL] [Abstract][Full Text] [Related]
9. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of motor dysfunction in the rat model of NGLY1 deficiency.
Asahina M; Fujinawa R; Hirayama H; Tozawa R; Kajii Y; Suzuki T
Mol Brain; 2021 Jun; 14(1):91. PubMed ID: 34120625
[TBL] [Abstract][Full Text] [Related]
11. Endo-β-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells.
Huang C; Harada Y; Hosomi A; Masahara-Negishi Y; Seino J; Fujihira H; Funakoshi Y; Suzuki T; Dohmae N; Suzuki T
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1398-403. PubMed ID: 25605922
[TBL] [Abstract][Full Text] [Related]
12. A commentary on 'Patient-derived gene and protein expression signatures of NGLY1 deficiency'.
Suzuki T
J Biochem; 2024 Mar; 175(3):221-223. PubMed ID: 38156787
[TBL] [Abstract][Full Text] [Related]
13. NGLY1: insights from Caenorhabditis elegans.
Lehrbach NJ
J Biochem; 2022 Feb; 171(2):145-152. PubMed ID: 34697631
[TBL] [Abstract][Full Text] [Related]
14. Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene.
Fujihira H; Masahara-Negishi Y; Tamura M; Huang C; Harada Y; Wakana S; Takakura D; Kawasaki N; Taniguchi N; Kondoh G; Yamashita T; Funakoshi Y; Suzuki T
PLoS Genet; 2017 Apr; 13(4):e1006696. PubMed ID: 28426790
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
Bi Y; Might M; Vankayalapati H; Kuberan B
Bioorg Med Chem Lett; 2017 Jul; 27(13):2962-2966. PubMed ID: 28512024
[TBL] [Abstract][Full Text] [Related]
16. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
Tambe MA; Ng BG; Freeze HH
Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
[TBL] [Abstract][Full Text] [Related]
17. NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology.
Pandey A; Adams JM; Han SY; Jafar-Nejad H
Cells; 2022 Mar; 11(7):. PubMed ID: 35406718
[No Abstract] [Full Text] [Related]
18. Physiological importance of NGLY1, as revealed by rodent model analyses.
Fujihira H; Asahina M; Suzuki T
J Biochem; 2022 Feb; 171(2):161-167. PubMed ID: 34580715
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
20. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder.
Suzuki T
J Biochem; 2015 Jan; 157(1):23-34. PubMed ID: 25398991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
